PipelineSTERNA BIOLOGICALS
Despite widespread corticosteroid use and the availability of biologicals, there is still an unmet need for safer, more efficacious anti-inflammatory treatments for chronic diseases.
sterna biologicals has completed multiple phase IIa clinical trials with topical formulations of hgd40 in a number of commercially attractive chronic inflammatory diseases with high unmet medical need.